UpHealth, Inc.
UPH · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $158,803 | $123,795 | $5,396 | – |
| % Growth | 28.3% | 2,194.2% | – | – |
| Cost of Goods Sold | $88,648 | $80,208 | $1,183 | – |
| Gross Profit | $70,155 | $43,587 | $4,213 | – |
| % Margin | 44.2% | 35.2% | 78.1% | – |
| R&D Expenses | $7,888 | $7,302 | $874 | – |
| G&A Expenses | $55,219 | $58,811 | $4,945 | – |
| SG&A Expenses | $71,170 | $68,086 | $4,945 | – |
| Sales & Mktg Exp. | $15,951 | $9,275 | $0 | – |
| Other Operating Expenses | $16,140 | $13,044 | $320 | – |
| Operating Expenses | $95,198 | $88,432 | $6,139 | – |
| Operating Income | -$25,043 | -$44,845 | -$1,926 | – |
| % Margin | -15.8% | -36.2% | -35.7% | – |
| Other Income/Exp. Net | -$207,276 | -$297,928 | -$210 | – |
| Pre-Tax Income | -$232,319 | -$342,773 | -$2,057 | – |
| Tax Expense | -$9,384 | -$2,437 | $50 | – |
| Net Income | -$222,935 | -$340,336 | -$2,107 | – |
| % Margin | -140.4% | -274.9% | -39% | – |
| EPS | -15.17 | -31.8 | -0.4 | – |
| % Growth | 52.3% | -7,850% | – | – |
| EPS Diluted | -15.17 | -31.8 | -0.4 | – |
| Weighted Avg Shares Out | 14,699 | 10,703 | 5,235 | – |
| Weighted Avg Shares Out Dil | 14,699 | 10,703 | 5,235 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $121 | $490 | $4 | – |
| Interest Expense | $26,500 | $19,516 | $134 | – |
| Depreciation & Amortization | $22,457 | $17,898 | $324 | – |
| EBITDA | -$156,983 | -$286,333 | -$1,678 | – |
| % Margin | -98.9% | -231.3% | -31.1% | – |